Cambrex and Dow open facility in Sweden for producing Dow’s HPMCAS products

9:40 AM MDT | October 30, 2013 | Deepti Ramesh

Cambrex (East Rutherford, NJ) and Dow Chemical say they have opened a previously announced new facility at the Cambrex Karlskoga (Karlskoga, Sweden) site for manufacturing Dow’s hydroxypropyl methylcellulose acetate succinate (HPMCAS) for drug solubility enhancement. Cambrex and Dow, earlier this year, executed an agreement for Cambrex to contract manufacture Dow’s HPMCAS, and, as part of this agreement, the new plant was constructed at Karlskoga. The facility completion and start of the HPMCAS product validation marks a year-long journey that began...